On September 1, 2021, the Board of Directors of Infinity Pharmaceuticals, Inc. upon recommendation from the Nominating and Corporate Governance Committee of the Board, expanded the size of the Board from six to seven members and elected Dr. Brian Schwartz as a member of the Board, effective September 7, 2021. Dr. Schwartz will serve as a director with a term expiring at the Company's 2022 annual meeting of stockholders and thereafter until his successor has been duly elected and qualified or until his earlier death, resignation or removal. Dr. Schwartz was also elected to serve on the Research and Development Committee of the Board.